ArticleJournal of translational medicine2024

Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile.

Tao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.